A case of self-limited drug induced liver injury under treatment with elexacaftor/tezacaftor/ivacaftor: When it is worth taking the risk

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)712-714
Number of pages3
JournalJournal of Cystic Fibrosis
Volume20
Issue number4
DOIs
Publication statusPublished - Jul 2021

Keywords

  • case
  • self-limited drug induced liver injury
  • treatment
  • elexacaftor
  • tezacaftor
  • ivacaftor

Cite this